提高资产管理效率
Search documents
众业达电气股份有限公司 关于注销控股孙公司的公告
Zhong Guo Zheng Quan Bao - Zhong Zheng Wang· 2026-02-26 22:37
Group 1 - The company has recently canceled its wholly-owned subsidiary, Yibin Hongda New Energy Technology Co., Ltd., to optimize its investment structure, reduce management costs, and improve asset management efficiency [1][3] - Yibin Hongda was established on January 9, 2018, with a registered capital of 100,000 yuan and operated in various sectors including technology promotion, charging stations, and electrical equipment repair [2] - The cancellation will not significantly impact the company's overall business development and profitability, and it does not harm the interests of the listed company and its shareholders [3]
众业达(002441.SZ):拟注销控股孙公司
Ge Long Hui A P P· 2026-02-26 07:59
Group 1 - The core viewpoint of the article is that Zhongyeda Electric Co., Ltd. has recently canceled its wholly-owned subsidiary, Yibin Hongda New Energy Technology Co., Ltd., to optimize its investment structure, reduce management costs, and improve asset management efficiency [1] Group 2 - The cancellation of Yibin Hongda is part of a strategic move by the company to enhance operational efficiency [1] - This decision reflects the company's focus on streamlining its operations and potentially reallocating resources to more profitable ventures [1] - The action indicates a proactive approach to managing its investment portfolio in the new energy sector [1]
众业达:拟注销控股孙公司
Ge Long Hui· 2026-02-26 07:51
Group 1 - The core viewpoint of the article is that Zhongyeda Electric Co., Ltd. has recently canceled its wholly-owned subsidiary, Yibin Hongda New Energy Technology Co., Ltd., to optimize its investment structure and improve asset management efficiency [1] Group 2 - The cancellation of Yibin Hongda is part of the company's strategy to reduce management costs [1] - The decision aims to enhance the overall efficiency of asset management within the company [1]
多瑞医药:拟注销全资子公司西藏晨韵实业有限公司
Ge Long Hui· 2026-01-22 09:09
Group 1 - The core viewpoint of the article is that Duori Pharmaceutical (301075.SZ) has recently dissolved its wholly-owned subsidiary, Tibet Chenyun Industrial Co., Ltd., to enhance asset management efficiency, optimize investment structure, and reduce management costs [1] Group 2 - The dissolution of Tibet Chenyun is part of the company's strategy to streamline operations and improve overall financial performance [1]